Menu
Back to Journals » International Medical Case Reports Journal » Volume 14
Successful Treatment of Bacillus licheniformis Peritonitis in Peritoneal Dialysis Patient with Intraperitoneal Vancomycin: A Case Report
Authors Albaker W
Received 11 February 2021
Accepted for publication 24 March 2021
Published 7 April 2021 Volume 2021:14 Pages 215—218
DOI https://doi.org/10.2147/IMCRJ.S305902
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Professor Ronald Prineas
Waleed Albaker
Department of Internal Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Al-Khobar, Saudi Arabia
Correspondence: Waleed Albaker
Department of Internal Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Al-Khobar, 40246, Saudi Arabia
Email [email protected]
Abstract: Bacillus licheniformis is a rare pathogen causing peritonitis in peritoneal dialysis (PD) patients, and it is usually recognized among immunosuppressed or traumatized patients. A 24-year-old lady was treated for peritonitis as an outpatient with empirical therapy. PD culture grew Bacillus licheniformis after 48 hours, and she continued receiving intraperitoneal (IP) vancomycin for a total of three weeks. The patient was clinically stable throughout the course of therapy and showed complete resolution of her symptoms. This was the first case of reported Bacillus peritonitis in an automated peritoneal dialysis (APD) patient with rapid clinical and biochemical improvement without evidence of relapse or recurrence.
Keywords: peritonitis, Bacillus licheniformis, automated peritoneal dialysis, APD, vancomycin
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.